Cargando…
Broad and potent cross clade neutralizing antibodies with multiple specificities in the plasma of HIV-1 subtype C infected individuals
Broadly Cross clade Neutralizing (BCN) antibodies are recognized as potential therapeutic tools and leads for the design of a vaccine that can protect human beings against various clades of Human Immunodeficiency Virus (HIV). In the present study, we screened plasma of 88 HIV-1 infected ART naïve in...
Autores principales: | Cheedarla, Narayanaiah, Precilla, K. Lucia, Babu, Hemalatha, Vijayan, K. K. Vidya, Ashokkumar, Manickam, Chandrasekaran, Padmapriyadarsini, Kailasam, Nandagopal, Sundaramurthi, Jagadish Chandrabose, Swaminathan, Soumya, Buddolla, Viswanath, Vaniambadi, S. Kalyanaraman, Ramanathan, V. D., Hanna, Luke Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402285/ https://www.ncbi.nlm.nih.gov/pubmed/28436427 http://dx.doi.org/10.1038/srep46557 |
Ejemplares similares
-
Evolution of Neutralization Response in HIV-1 Subtype C-Infected Individuals Exhibiting Broad Cross-Clade Neutralization of HIV-1 Strains
por: Cheedarla, Narayanaiah, et al.
Publicado: (2018) -
Cross Type Neutralizing Antibodies Detected in a Unique HIV-2 Infected Individual From India
por: Vidyavijayan, K. K., et al.
Publicado: (2018) -
HLA-A*0201-specific epitopes of Indian HIV-1C as candidates for vaccine design
por: Sundaramurthi, Jagadish Chandrabose, et al.
Publicado: (2012) -
Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis
por: Gopalan, Narendran, et al.
Publicado: (2016) -
Molecular docking of azole drugs and their analogs on CYP121 of Mycobacterium tuberculosis
por: Sundaramurthi, Jagadish Chandrabose, et al.
Publicado: (2011)